Eating Disorder Inventory also includes questions specific to the behavioral patterns of someone with or at risk of developing an eating disorder. The EDI-3RF also utilizes referral indexes based on Body Mass Index (BMI) in identifying at risk patients. SCOFF questionnaire<br> Body Attitudes Test<br> Bulimia Test-Revised<br> Eating Attitudes Test<br> Body Attitudes Questionnaire<br> Eating Disorder Examination Interview<br> Diagnostic classification and rating scales used in psychiatry<br> Eating Disorder Inventory The Eating Disorder Inventory (EDI) is a self-report questionnaire used to assess the presence of eating disorders, (a) Anorexia Nervosa both restricting and binge-eating/purging type; (b) Bulimia Nervosa; and (c) Eating disorder not otherwise specified including
Binge eating disorder is used for the treatment of moderate to severe binge eating disorder in adults. Three other classes of medications are also used in the treatment of binge eating disorder: antidepressants, anticonvulsants, and anti-obesity medications. Antidepressant medications of the selective serotonin reuptake inhibitor (SSRI) class such as fluoxetine, fluvoxamine, or sertraline have been found to effectively reduce episodes of binge eating and reduce weight. Similarly, anticonvulsant medications such as topiramate and zonisamide may be able to effectively suppress appetite. The long-term effectiveness of medication for binge eating disorder is currently unknown. Trials of antidepressants, anticonvulsants, and anti-obesity medications suggest that these